Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10605027rdf:typepubmed:Citationlld:pubmed
pubmed-article:10605027lifeskim:mentionsumls-concept:C0439849lld:lifeskim
pubmed-article:10605027lifeskim:mentionsumls-concept:C0030956lld:lifeskim
pubmed-article:10605027lifeskim:mentionsumls-concept:C0282580lld:lifeskim
pubmed-article:10605027lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:10605027lifeskim:mentionsumls-concept:C1704259lld:lifeskim
pubmed-article:10605027lifeskim:mentionsumls-concept:C0439064lld:lifeskim
pubmed-article:10605027lifeskim:mentionsumls-concept:C0439801lld:lifeskim
pubmed-article:10605027lifeskim:mentionsumls-concept:C1705987lld:lifeskim
pubmed-article:10605027lifeskim:mentionsumls-concept:C0445223lld:lifeskim
pubmed-article:10605027lifeskim:mentionsumls-concept:C0443288lld:lifeskim
pubmed-article:10605027lifeskim:mentionsumls-concept:C1552599lld:lifeskim
pubmed-article:10605027lifeskim:mentionsumls-concept:C1261552lld:lifeskim
pubmed-article:10605027lifeskim:mentionsumls-concept:C1704787lld:lifeskim
pubmed-article:10605027lifeskim:mentionsumls-concept:C1880371lld:lifeskim
pubmed-article:10605027pubmed:issue1lld:pubmed
pubmed-article:10605027pubmed:dateCreated2000-1-19lld:pubmed
pubmed-article:10605027pubmed:abstractTextThe influence of various factors along the processing-loading pathway in limiting the diversity of HLA-B27-bound peptides around a core protein sequence was analyzed. The C5 proteasome subunit-derived RRFFPYYV and RRFFPYYVY peptides are natural B*2705 ligands. The octamer is an allospecific CTL epitope. Digestion of a 27-mer fragment of C5 revealed that both ligands are generated from this precursor substrate with the 20S proteasome in vitro in a ratio comparable to that in the B*2705-bound peptide pool. The C5 sequence allowed to derive a nested set of six additional peptides with 8-11 residues containing the core octamer sequence and the Arg2 motif of HLA-B27, none of which was found in the B27-bound pool. Together, low proteasomal yield, disfavored TAP-binding motifs, and low affinity for B*2705 accounted for the absence of four of the six peptides. The two remaining differed from the natural octamer or nonamer ligands only by an additional N-terminal Ser residue. Their stability in complex with B*2705 was lower than the respective natural ligands, raising the possibility that N-terminal trimming might have favored a shift toward the more stable peptides. The results suggest that the B*2705-bound peptide repertoire has a highly restricted diversity around a core alloantigenic sequence. This is not explained by a single bottleneck feature, but by multiple factors, including proteasomal generation, TAP-binding motifs, MHC-binding efficiency, and perhaps optimized stability through N-terminal trimming. Tapasin-dependent restrictions, although not excluded, were not required to explain the absence in vivo of the particular peptide set in this study.lld:pubmed
pubmed-article:10605027pubmed:languageenglld:pubmed
pubmed-article:10605027pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10605027pubmed:citationSubsetAIMlld:pubmed
pubmed-article:10605027pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10605027pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10605027pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10605027pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10605027pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10605027pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10605027pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10605027pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10605027pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10605027pubmed:statusMEDLINElld:pubmed
pubmed-article:10605027pubmed:monthJanlld:pubmed
pubmed-article:10605027pubmed:issn0022-1767lld:pubmed
pubmed-article:10605027pubmed:authorpubmed-author:AlvarezIIlld:pubmed
pubmed-article:10605027pubmed:authorpubmed-author:RamosMMlld:pubmed
pubmed-article:10605027pubmed:authorpubmed-author:VázquezJJlld:pubmed
pubmed-article:10605027pubmed:authorpubmed-author:ParadelaAAlld:pubmed
pubmed-article:10605027pubmed:authorpubmed-author:García-Peydró...lld:pubmed
pubmed-article:10605027pubmed:authorpubmed-author:López De...lld:pubmed
pubmed-article:10605027pubmed:authorpubmed-author:SesmaLLlld:pubmed
pubmed-article:10605027pubmed:issnTypePrintlld:pubmed
pubmed-article:10605027pubmed:day1lld:pubmed
pubmed-article:10605027pubmed:volume164lld:pubmed
pubmed-article:10605027pubmed:ownerNLMlld:pubmed
pubmed-article:10605027pubmed:authorsCompleteYlld:pubmed
pubmed-article:10605027pubmed:pagination329-37lld:pubmed
pubmed-article:10605027pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10605027pubmed:meshHeadingpubmed-meshheading:10605027...lld:pubmed
pubmed-article:10605027pubmed:meshHeadingpubmed-meshheading:10605027...lld:pubmed
pubmed-article:10605027pubmed:meshHeadingpubmed-meshheading:10605027...lld:pubmed
pubmed-article:10605027pubmed:meshHeadingpubmed-meshheading:10605027...lld:pubmed
pubmed-article:10605027pubmed:meshHeadingpubmed-meshheading:10605027...lld:pubmed
pubmed-article:10605027pubmed:meshHeadingpubmed-meshheading:10605027...lld:pubmed
pubmed-article:10605027pubmed:meshHeadingpubmed-meshheading:10605027...lld:pubmed
pubmed-article:10605027pubmed:meshHeadingpubmed-meshheading:10605027...lld:pubmed
pubmed-article:10605027pubmed:meshHeadingpubmed-meshheading:10605027...lld:pubmed
pubmed-article:10605027pubmed:meshHeadingpubmed-meshheading:10605027...lld:pubmed
pubmed-article:10605027pubmed:meshHeadingpubmed-meshheading:10605027...lld:pubmed
pubmed-article:10605027pubmed:meshHeadingpubmed-meshheading:10605027...lld:pubmed
pubmed-article:10605027pubmed:meshHeadingpubmed-meshheading:10605027...lld:pubmed
pubmed-article:10605027pubmed:meshHeadingpubmed-meshheading:10605027...lld:pubmed
pubmed-article:10605027pubmed:meshHeadingpubmed-meshheading:10605027...lld:pubmed
pubmed-article:10605027pubmed:meshHeadingpubmed-meshheading:10605027...lld:pubmed
pubmed-article:10605027pubmed:meshHeadingpubmed-meshheading:10605027...lld:pubmed
pubmed-article:10605027pubmed:meshHeadingpubmed-meshheading:10605027...lld:pubmed
pubmed-article:10605027pubmed:year2000lld:pubmed
pubmed-article:10605027pubmed:articleTitleLimited diversity of peptides related to an alloreactive T cell epitope in the HLA-B27-bound peptide repertoire results from restrictions at multiple steps along the processing-loading pathway.lld:pubmed
pubmed-article:10605027pubmed:affiliationCentro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid, Facultad de Ciencias, Spain.lld:pubmed
pubmed-article:10605027pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10605027pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10605027lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10605027lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10605027lld:pubmed